Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease (Q42434605)
Jump to navigation
Jump to search
scientific article published on 18 July 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease |
scientific article published on 18 July 2008 |
Statements
1 reference
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease (English)
1 reference
Rodrigo A Quintanilla
1 reference
Youngnam N Jin
1 reference
Karen Fuenzalida
1 reference
Miguel Bronfman
1 reference
Gail V W Johnson
1 reference
18 July 2008
1 reference
1 reference
283
1 reference
25628-25637
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference